Novozymes B A/S/ DK0060336014 /
3/30/2023 4:59:57 PM | Chg. +0.70 | Volume | Bid5:10:00 PM | Ask5:10:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
349.00DKK | +0.20% | 826,744 Turnover: 275.74 mill. |
349.10Bid Size: 488 | 349.40Ask Size: 210 | 79.66 bill.DKK | 1.58% | 30.83 |
Fundamentals
FY 2021 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 11.32 DKK | 12.41% |
EPS Diluted: | 11.23 DKK | 12.08% |
Revenues per Share: | 65.50 DKK | 8.10% |
Book Value per Share: | 51.81 DKK | 6.67% |
Cash Flow per Share: | 17.80 DKK | -5.50% |
Dividend per Share: | 5.50 DKK | 4.76% |
Total | in mill. | |
Revenues: | 14,951.00 DKK | 6.70% |
Net Income: | 3,145.00 DKK | 11.33% |
Operating Cash Flow: | 4,062.00 DKK | - |
Cash and Cash Equivalents: | 963.00 DKK | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 30.83 | 47.46 |
P/S Ratio: | 5.33 | 8.20 |
P/BV ratio: | 6.74 | 10.37 |
P/CF Ratio: | 19.61 | 30.19 |
PEG: | 2.48 | 3.82 |
Earnings Yield: | 3.24% | 2.11% |
Dividend Yield: | 1.58% | 1.02% |
Market Capitalization | ||
Market Capitalization: | 79.66 bill. DKK | 122.62 bill. DKK |
Free Float Market Cap.: | 59.35 bill. DKK | 91.35 bill. DKK |
Market Cap. / Employee: | 12.2 mill. DKK | 18.79 mill. DKK |
Shares Outstanding: | 228.26 mill. |
Profitability
Gross Profit Margin: | 57.68% |
EBIT Margin: | 26.80% |
Net Profit Margin: | 21.04% |
Return on Equity: | 26.59% |
Return on Assets: | 12.70% |
Financial Strength
Liquidity I / Cash Ratio: | 16.98% |
Liquidity II / Quick Ratio: | 68.94% |
Liquidity III / Current Ratio: | 137.90% |
Debt / Equity Ratio: | 109.41% |
Dynam. Debt / Equity Ratio: | 318.56% |
Efficiency
Employees: | 6,527 |
Personal Expenses / Employee: | 630,151.68 DKK |
Revenues / Employee: | 2,290,638.88 DKK |
Net Income / Employee: | 481,844.65 DKK |
Total Assets / Employee: | 3,794,545.73 DKK |
* Fiscal Year End: | 12/31/2021 |
Accounting Standard: | IFRS |
Currency: | DKK |